We are live on ! Find out more
CLPT icon

ClearPoint Neuro
CLPT

50 hedge funds and large institutions have $45.4M invested in ClearPoint Neuro in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 16 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

760% more call options, than puts

Call options by funds: $2.44M | Put options by funds: $284K

5.38% less ownership

Funds ownership: 20.07% → 14.69% (-5.4%)

8% less capital invested

Capital invested by funds: $49.5M → $45.4M (-$4.05M)

22% less funds holding

Funds holding: 64 → 50 (-14)

38% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 16

46% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 28

Holders
50
Holders Change
-14
Holders Change %
-21.88%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
10
Reduced
16
Closed
28
Calls
$2.44M
Puts
$284K
Net Calls
+$2.16M
Net Calls Change
+$1.85M

Top Buyers

Rank Fund Capital Flow
1
Brown Advisory
Brown Advisory
Maryland
+$2.06M
2
Millennium Management
Millennium Management
New York
+$1.95M
3
EIM
Essex Investment Management
Massachusetts
+$1.08M
4
E
Ergoteles
New York
+$935K
5
EI
EAM Investors
California
+$898K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$8.91M
2
State Street
State Street
Massachusetts
-$2.53M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.61M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.47M
5
Northern Trust
Northern Trust
Illinois
-$1.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
76
Credit Suisse
Switzerland
– +$102 +10 New
1 2 3
4

CLPT Hedge Fund Activity: Q2 2022 in Review

50 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q2 2022, worth a combined $45.4M — down 8.2% from $49.5M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of CLPT and 15 opened new positions — a net loss of 13 holders — while 16 trimmed existing stakes and 10 added.

The largest buyer was Brown Advisory, adding an estimated $2.06M. The largest seller was BlackRock, cutting an estimated $8.91M.

  • 50 institutional investors held ClearPoint Neuro (CLPT) as of Q2 2022, down from 64 in Q1 2022.
  • Funds reported $45.4M of ClearPoint Neuro stock for Q2 2022, down 8.2% quarter-over-quarter.
  • 15 funds opened new ClearPoint Neuro positions in Q2 2022 and 28 closed out, a net change of -13 holders.
  • The largest ClearPoint Neuro buyer in Q2 2022 was Brown Advisory, an estimated $2.06M added.
  • The largest ClearPoint Neuro seller in Q2 2022 was BlackRock, an estimated $8.91M sold.

Based on aggregated 13F filings for Q2 2022.